Amer Rafiaa MD in Brooklyn, New York

Home New York Brooklyn

Amer Rafiaa MD has Hematology/oncology as his primary medical specialty. Their primary office is: 149 Congress St in Brooklyn, New York. There is an additional office location, for a total of two, for Amer Rafiaa MD that can be viewed further down. They attended Sorry, his university is not listed and graduated in 1988 (around 36 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Amer Rafiaa MD Office Phone and Directions

Amer Rafiaa MD
149 Congress St
Brooklyn, New York 11201
718-680-1404

Patient Ratings
Please rate your experience with Amer Rafiaa MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 718-680-1404

Enter a starting address:

Healthcare Info for Amer Rafiaa MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1988
The Primary Medical Specialty for Amer Rafiaa MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 36
PAC (PECOS ID)#: 2961411244
NPI #: 1427022656
NPI Created On: 02/14/2006
NPI Last Updated Listed as: 10/26/2023
Primary Taxonomy Code: 207RH0003X
License Number:
209217
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Arabic.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Vaccine for influenza for administration into muscle, 0.5 ml dosage
Hydration infusion into a vein
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy, prevention, or diagnosis
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 15 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Hospital discharge day management, 30 minutes or less
Initial nursing facility visit, typically 35 minutes per day
Initial nursing facility visit, typically 45 minutes per day
Subsequent nursing facility visit, typically 10 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $85

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788220201

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788220203

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818934957

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: VERZENIO

Associated Drug #2: 0002-6216-54

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: RETEVMO

Name Of Drug #3: 0002-2980-60

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818934961

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818939963

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: VERZENIO

Associated Drug #2: 0002-6216-54

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: RETEVMO

Name Of Drug #3: 0002-2980-60

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832138399

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $20

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783508465

Being Disputed:: No

Product Related: No

Payments Total: $18

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783508495

Being Disputed:: No

Product Related: No

Payments Total: $17

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783508511

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $23

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783508529

Being Disputed:: No

Product Related: No

Additional Office Locations

1.
445 Bay Ridge Pkwy
Brooklyn, NY 11209
Group Members: 0

Phone: 718-680-1404

Enter a starting address:

Hematology/oncology Professionals in Brooklyn

1.
Valeria Kreyner

500 4th Ave
Brooklyn, NY
Dosik Hematology And Oncology Pc

2.
Edouard Guillaume MD

1545 Atlantic Ave
Brooklyn, NY
Interfaith Professional Physician Services Pc

3.
Mark Sonnenschine

4802 10th Ave
Brooklyn, NY

4.
Mark Sonnenschine

705 Ave U
Brooklyn, NY

5.
Mark Sonnenschine

2601 Ocean Pkwy
Brooklyn, NY
Coney Island Medical Practice Plan, P.c.

6.
Songchuan Guo

8686 Bay Pkwy
Brooklyn, NY
Chinatown True Care Medical Pllc

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry